Monte Rosa Therapeutics, Inc. (GLUE) vs MannKind Corporation (MNKD)
Monte Rosa Therapeutics, Inc. and MannKind Corporation are both Biotechnology companies. Monte Rosa Therapeutics, Inc. and MannKind Corporation are of similar size ($1.1B and $999.9M). MannKind Corporation grew revenue faster over the last twelve months: 30.5% against −83.9%. MannKind Corporation has the higher net margin (−11.1% vs −560.9%) and the higher return on invested capital (2.36% vs 0.00%). Across the 16 metrics below, MannKind Corporation leads on 13 and Monte Rosa Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | GLUE | MNKD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 75.39% | 65.16% |
| Operating margin | (633.04%) | 2.34% | 0.00% |
| Net margin | (560.85%) | (11.08%) | 0.00% |
| Free cash flow margin | (111.66%) | (4.61%) | 0.00% |
| Return on equity | (42.66%) | 71.36% | (57.72%) |
| Return on assets | (30.67%) | (7.62%) | (49.22%) |
| Return on invested capital | 0.00% | 2.36% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack